Three ways GLP-1s are about to change America.

The move could unlock millions of new patients for Novo Nordisk and Eli Lilly and expand access to medications that were previously out of reach for seniors.

Popular Novo Nordisk and Eli Lilly drugs are included

Medicare enrollees as of July 1 can get GLP-1s covered by Part D prescription insurance as part of a trial program until the end of 2027.